Cas:155053-64-8 ethyl 3-amino-3-hydrazinylidenepropanoate manufacturer & supplier

We serve Chemical Name:ethyl 3-amino-3-hydrazinylidenepropanoate CAS:155053-64-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl 3-amino-3-hydrazinylidenepropanoate

Chemical Name:ethyl 3-amino-3-hydrazinylidenepropanoate
CAS.NO:155053-64-8
Synonyms:3-HYDRAZINYL-3-IMINO-PROPANOIC ACID ETHYL ESTER;Propanoicacid,3-hydrazino-3-imino-,ethyl ester (9CI);Propanoic acid,3-hydrazinyl-3-imino-,ethyl ester
Molecular Formula:C5H11N3O2
Molecular Weight:145.16000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:90.70000
Exact Mass:145.08500
LogP:0.57110

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-HYDRAZINYL-3-IMINO-PROPANOIC ACID ETHYL ESTER chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Propanoic acid,3-hydrazinyl-3-imino-,ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Propanoic acid,3-hydrazinyl-3-imino-,ethyl ester Use and application,Propanoic acid,3-hydrazinyl-3-imino-,ethyl ester technical grade,usp/ep/jp grade.


Related News: The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace. ethyl 3-amino-3-hydrazinylidenepropanoate manufacturer Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs. ethyl 3-amino-3-hydrazinylidenepropanoate supplier As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. ethyl 3-amino-3-hydrazinylidenepropanoate vendor Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs). ethyl 3-amino-3-hydrazinylidenepropanoate factory Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.